Is The FDA Being Compromised By Pharma Payments?

Forbes John LaMattina,  8/07/2013    In touting an upcoming special issue of the Journal of Law, Medicine and Ethics (JLME), Donald W. Light of the School of Public Health, University of Medicine & Dentistry of NJ, wrote an article entitled “Risky Drugs: Why The FDA Cannot Be Trusted”. Last week I discussed one aspect of this article, Light’s challenge that 90% of FDA approved drugs of the last 30 years are no more effective than existing drugs. However, the bulk of his essay focuses not on his views about pharma’s competence but rather on his issues with the FDA. While I found a number of his comments troubling, the following stood out.  Read more